Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa
- PMID: 36459247
- PMCID: PMC10416081
- DOI: 10.1007/s00467-022-05831-8
Hiding in plain sight: genetics of childhood steroid-resistant nephrotic syndrome in Sub-Saharan Africa
Abstract
Steroid-resistant nephrotic syndrome (SRNS) is the most severe form of childhood nephrotic syndrome with an increased risk of progression to chronic kidney disease stage 5. Research endeavors to date have identified more than 80 genes that are associated with SRNS. Most of these genes regulate the structure and function of the podocyte, the visceral epithelial cells of the glomerulus. Although individuals of African ancestry have the highest prevalence of SRNS, especially those from Sub-Saharan Africa (SSA), with rates as high as 30-40% of all cases of nephrotic syndrome, studies focusing on the characterization and understanding of the genetic basis of SRNS in the region are negligible compared with Europe and North America. Therefore, it remains unclear if some of the variants in SRNS genes that are deemed pathogenic for SRNS are truly disease causing, and if the leading causes of monogenic nephrotic syndrome in other populations are the same for children in SSA with SRNS. Other implications of this lack of genetic data for SRNS in the region include the exclusion of children from the region from clinical trials aimed at identifying potential novel therapeutic agents for this severe form of nephrotic syndrome. This review underlines a need for concerted efforts to advance the genetic basis of SRNS in children in SSA. Such endeavors will complement global efforts at understanding the genetic basis of nephrotic syndrome.
Keywords: Africa; Genetic SRNS; Nephrotic syndrome; Pediatrics; SRNS.
© 2022. The Author(s), under exclusive licence to International Pediatric Nephrology Association.
Conflict of interest statement
Disclosures
None of the authors in this study has conflicts of interest to disclose.
Figures
![Figure 1:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab0/10416081/1bb88aa2f0f4/nihms-1922821-f0001.gif)
![Figure 2:](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5ab0/10416081/ada9e4ace381/nihms-1922821-f0002.gif)
Similar articles
-
Causal and putative pathogenic mutations identified in 39% of children with primary steroid-resistant nephrotic syndrome in South Africa.Eur J Pediatr. 2022 Oct;181(10):3595-3606. doi: 10.1007/s00431-022-04581-x. Epub 2022 Aug 3. Eur J Pediatr. 2022. PMID: 35920919 Free PMC article.
-
Use of genomic and functional analysis to characterize patients with steroid-resistant nephrotic syndrome.Pediatr Nephrol. 2018 Oct;33(10):1741-1750. doi: 10.1007/s00467-018-3995-2. Epub 2018 Jul 7. Pediatr Nephrol. 2018. PMID: 29982877
-
HLA-DQA1 and APOL1 as Risk Loci for Childhood-Onset Steroid-Sensitive and Steroid-Resistant Nephrotic Syndrome.Am J Kidney Dis. 2018 Mar;71(3):399-406. doi: 10.1053/j.ajkd.2017.10.013. Epub 2017 Dec 23. Am J Kidney Dis. 2018. PMID: 29277510 Free PMC article.
-
Genetic testing in steroid-resistant nephrotic syndrome: why, who, when and how?Pediatr Nephrol. 2019 Feb;34(2):195-210. doi: 10.1007/s00467-017-3838-6. Epub 2017 Nov 27. Pediatr Nephrol. 2019. PMID: 29181713 Free PMC article. Review.
-
Genetic testing in steroid-resistant nephrotic syndrome: when and how?Nephrol Dial Transplant. 2016 Nov;31(11):1802-1813. doi: 10.1093/ndt/gfv355. Epub 2015 Oct 27. Nephrol Dial Transplant. 2016. PMID: 26507970 Free PMC article. Review.
Cited by
-
Urine-derived podocytes from steroid resistant nephrotic syndrome patients as a model for renal-progenitor derived extracellular vesicles effect and drug screening.J Transl Med. 2024 Aug 14;22(1):762. doi: 10.1186/s12967-024-05575-z. J Transl Med. 2024. PMID: 39143486 Free PMC article.
-
"Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F685-F694. doi: 10.1152/ajprenal.00219.2023. Epub 2023 Oct 5. Am J Physiol Renal Physiol. 2023. PMID: 37795536 Free PMC article. Review.
-
Clinical Characteristics, Pathological Features and Treatment Outcomes of Children With Nephrotic Syndrome at Princess Marina Hospital, Botswana.Glob Pediatr Health. 2024 Oct 5;11:2333794X241285272. doi: 10.1177/2333794X241285272. eCollection 2024. Glob Pediatr Health. 2024. PMID: 39376930 Free PMC article.
References
-
- Banh TH, Hussain-Shamsy N, Patel V, Vasilevska-Ristovska J, Borges K, Sibbald C, Lipszyc D, Brooke J, Geary D, Langlois V, Reddon M, Pearl R, Levin L, Piekut M, Licht CP, Radhakrishnan S, Aitken-Menezes K, Harvey E, Hebert D, Piscione TD, Parekh RS (2016) Ethnic Differences in Incidence and Outcomes of Childhood Nephrotic Syndrome. Clin J Am Soc Nephrol 11:1760–1768 - PMC - PubMed
-
- Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet. 392:61–74. - PubMed
-
- Wong W (2007) Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health 43:337–341 - PubMed
-
- McKinney PA, Feltbower RG, Brocklebank JT, Fitzpatrick MM (2001) Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK. Pediatr Nephrol 16:1040–1044 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials